应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
03692 翰森制药
交易中 06-24 14:23:14
29.560
-0.040
-0.14%
最高
30.540
最低
29.220
成交量
918.52万
今开
29.680
昨收
29.600
日振幅
4.46%
总市值
1,793亿
流通市值
1,793亿
总股本
60.64亿
成交额
2.75亿
换手率
0.15%
流通股本
60.64亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
异动解读｜翰森制药盘中上涨3.18%，获国盛证券首次覆盖给予买入评级
行情直击 · 10:35
异动解读｜翰森制药盘中上涨3.18%，获国盛证券首次覆盖给予买入评级
【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大
金吾财讯 · 06-15
【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大
翰森制药HS-10,568注射液新药上市申请获中国药监局受理 用于治疗成人慢性肾病继发性甲状旁腺功能亢进
美股速递 · 06-10
翰森制药HS-10,568注射液新药上市申请获中国药监局受理 用于治疗成人慢性肾病继发性甲状旁腺功能亢进
翰森制药(03692)：HS-10568注射液上市许可申请获国家药品监督管理局受理
智通财经 · 06-10
翰森制药(03692)：HS-10568注射液上市许可申请获国家药品监督管理局受理
翰森制药(03692)：郭颖获委任为联席公司秘书
智通财经 · 06-10
翰森制药(03692)：郭颖获委任为联席公司秘书
港股开盘受压 恒指低开0.5% 药明生物(02269)跌4.88%
金吾财讯 · 06-10
港股开盘受压 恒指低开0.5% 药明生物(02269)跌4.88%
新华健康丨翰森制药双靶点GLP-1减重药奥莱泊肽NDA获受理 将面临激烈市场竞争
经济参考网 · 06-05
新华健康丨翰森制药双靶点GLP-1减重药奥莱泊肽NDA获受理 将面临激烈市场竞争
《21健讯Daily》|翰森制药减重新药申报上市；艾德生物复牌
21世纪经济报道 · 06-05
《21健讯Daily》|翰森制药减重新药申报上市；艾德生物复牌
翰森制药拟回购最多10%股份
公告速递 · 06-04
翰森制药拟回购最多10%股份
国产双靶点GLP-1迎新进展，翰森制药减重新药申报获受理｜医药早参
每日经济新闻 · 06-04
国产双靶点GLP-1迎新进展，翰森制药减重新药申报获受理｜医药早参
翰森制药(03692)：奥莱泊肽注射液上市许可申请获国家药品监督管理局受理
智通财经 · 06-04
翰森制药(03692)：奥莱泊肽注射液上市许可申请获国家药品监督管理局受理
翰森制药：奥拉托肽注射液新药上市申请获中国国家药监局受理 用于慢性体重管理
美股速递 · 06-04
翰森制药：奥拉托肽注射液新药上市申请获中国国家药监局受理 用于慢性体重管理
翰森制药5月股份变动月报表：股本维持稳定
公告速递 · 06-02
翰森制药5月股份变动月报表：股本维持稳定
港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展
智通财经 · 05-28
港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展
异动解读｜翰森制药盘中下跌6.04%，报31.76港元
行情直击 · 05-28
异动解读｜翰森制药盘中下跌6.04%，报31.76港元
中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通
智通财经 · 05-25
中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通
翰森制药(03692)：第四代EGFR-TKI HS-10504片用于非小细胞肺癌纳入突破性治疗药物
智通财经 · 05-21
翰森制药(03692)：第四代EGFR-TKI HS-10504片用于非小细胞肺癌纳入突破性治疗药物
翰森制药(03692)：曾昭获委任为联席公司秘书、授权代表
智通财经 · 05-15
翰森制药(03692)：曾昭获委任为联席公司秘书、授权代表
翰森制药(03692)：HS-10541片获国家药监局签发的药物临床试验批准通知书
智通财经 · 05-13
翰森制药(03692)：HS-10541片获国家药监局签发的药物临床试验批准通知书
格隆汇个股放量排行榜 | 5月13日
格隆汇 · 05-13
格隆汇个股放量排行榜 | 5月13日
加载更多
公司概况
公司名称：
翰森制药
所属市场：
SEHK
上市日期：
--
主营业务：
翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统（CNS）疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。
发行价格：
--
{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":29.56,"timestamp":1782282187166,"preClose":29.6,"halted":0,"volume":9185170,"delay":0,"changeRate":-0.0013513513513514425,"floatShares":6064000000,"shares":6064000000,"eps":0.93,"marketStatus":"交易中","change":-0.04,"latestTime":"06-24 14:23:14","open":29.68,"high":30.54,"low":29.22,"amount":275371894,"amplitude":0.044595,"askPrice":29.58,"askSize":12000,"bidPrice":29.54,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":1.033788,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782288600000},"marketStatusCode":2,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":29.6,"dividendRate":0.015096,"openAndCloseTimeList":[[1782264600000,1782273600000],[1782277200000,1782288000000]],"volumeRatio":1.306433,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"1163006406","title":"异动解读｜翰森制药盘中上涨3.18%，获国盛证券首次覆盖给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1163006406","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163006406?lang=zh_cn&edition=full","pubTime":"2026-06-24 10:35","pubTimestamp":1782268535,"startTime":"0","endTime":"0","summary":"6月24日，翰森制药盘中上涨3.18%，报30.54港元，成交额1.75亿港元。消息面上，国盛证券近日首次覆盖翰森制药并给予\"买入\"评级，目标价40.61港元，对应37倍市盈率，较当前股价有约33%上行空间。此外，公司自主研发的GLP-1/GIP双靶点减重药奥莱泊肽NDA已获国家药监局受理，III期数据显示48周最高体重降幅达19.3%，恶心发生率不到10%，展现出\"强减重、优耐受\"特征，相关机制研究数据亦首次亮相全球内分泌领域顶级学术会议ENDO 2026。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643822932","title":"【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2643822932","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643822932?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:21","pubTimestamp":1781490116,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，医药行业在1H26表现整体稳健、但内部分化也较为明显。短期关注出海交易、业绩表现和利好政策落地。推荐高景气度赛道中、投资性价比较高的头部玩家，包括药明合联、凯莱英和康龙化成。2026年港股龙头收入和净利润增速有望稳定在双位数。板块复苏积极信号已经出现。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983754","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","01530","02162","06990","02596","01548","LU0456827905.SGD","LU0320764599.SGD","06160","IE00B0JY6N72.USD","03692","LU0819121731.USD","03759","06996","LU1226287875.USD","01177","LU1880383366.USD","HK0000306685.HKD","LU0140636845.USD","01093","00013","LU0348827113.USD","LU2097828631.EUR","06078","BK1191","02273","LU1242518857.USD","02268","01276","01801","IE00BZ08YR35.GBP","LU0051755006.USD","02269","02096","LU1688375341.USD","LU0502904849.HKD","HK0000320264.USD","09966","LU3063872942.SGD","01952","09996","BK1576","LU0737861772.HKD","SG9999002562.SGD","LU1960683339.HKD","09926","01951","03329","06821","LU0181495838.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102690614","title":"翰森制药HS-10,568注射液新药上市申请获中国药监局受理 用于治疗成人慢性肾病继发性甲状旁腺功能亢进","url":"https://stock-news.laohu8.com/highlight/detail?id=1102690614","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102690614?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:42","pubTimestamp":1781088138,"startTime":"0","endTime":"0","summary":"翰森制药集团宣布，其创新药物HS-10,568注射液用于治疗成人慢性肾脏病患者继发性甲状旁腺功能亢进的新药上市申请，已获得中国国家药品监督管理局的正式受理。此举标志着该药物在中国商业化进程中的关键一步，有望为相关患者群体提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1191","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642402384","title":"翰森制药(03692)：HS-10568注射液上市许可申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2642402384","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642402384?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:41","pubTimestamp":1781088108,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，于2026年6月9日，创新药HS-10568注射液(合作方代码SHR6508)上市许可申请(NDA)获中国国家药品监督管理局(NMPA)受理，适用于慢性肾脏病(CKD)接受血液透析的成人患者的继发性甲状旁腺功能亢进症 (SHPT)。HS-10568是一种钙敏感受体(CaSR)变构调节剂，可提高受体对细胞外钙的敏感性，从而减少甲状旁腺激素(PTH)的分泌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK1191","03692","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642440668","title":"翰森制药(03692)：郭颖获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2642440668","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642440668?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:31","pubTimestamp":1781087506,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，钟胜利女士已辞任公司联席公司秘书一职，自2026年6月10日起生效。郭颖女士已获委任为联席公司秘书，自2026年6月10日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642419555","title":"港股开盘受压 恒指低开0.5% 药明生物(02269)跌4.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642419555","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642419555?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:26","pubTimestamp":1781054819,"startTime":"0","endTime":"0","summary":"腾讯控股高开0.35%，公司宣布，公司对24.5亿美元及150亿元人民币票据进行定价。当中，10年期和20年期美元票据的本金额，分别为17.5亿美元及7亿美元，利率分别为5%及5.6%，发售价分别占本金额的99.689%及99.571%；10年期和30年期人民币票据的本金额，分别为110亿及40亿元人民币，利率分别为2.5%及3.1%，发售价分别占本金额的100%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"891af32a1eeea07164010ec7353ceace","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983427","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0737861772.HKD","BK1607","SGXZ99366536.SGD","TCHmain","LU2351347302.SGD","LU1226287875.USD","LU0502904849.HKD","03032","LU2348774022.SGD","07500","HHImain","07552","LU1023057109.AUD","LU1064130708.USD","LU0868486357.SGD","LU1115378108.SGD","LU1960683339.HKD","LU1481107354.HKD","LU1961090484.USD","LU1152091754.HKD","LU0348784397.USD","LU0348816934.USD","LU1102505762.USD","LU2187417386.USD","IE00BFXG0V08.USD","LU0880133367.SGD","LU1051768304.USD","HK0000914660.USD","LU2152927971.USD","SG9999014005.SGD","03993","LU1814569148.SGD","LU1981816686.USD","LU0210533765.USD","LU0348827113.USD","LU0348825331.USD","WXXWY","LU1226287792.SGD","LU1242518931.SGD","TCEHY","LU0069063385.USD","LU0543330566.HKD","LU2279701549.SGD","LU0823039010.USD","IE0004091025.USD","SG9999007991.SGD","LU0211331839.USD","03419","SG9999003461.SGD","LU0630378429.USD","LU0348767384.USD","02269","LU0348783662.USD","LU2097828805.USD","LU1400636491.USD","LU1242518857.USD","LU1363072403.SGD","LU1645745479.HKD","SG9999014898.SGD","LU0675040207.SGD","HK0000288743.USD","LU2213484517.USD","LU1152091168.USD","LU1880383366.USD","LU2106854487.HKD","IE0001KFT4U8.USD","IE0003895053.USD","IE00BPRC5H50.USD","NTES","LU1366334578.USD","LU0320764243.SGD","LU0918141705.HKD","LU0149534421.HKD","LU2089283258.USD","LU0651946864.USD","LU1303224171.USD","IE00BF5LJ272.USD","LU0251143458.SGD","LU0048580855.USD","LU1188198961.HKD","LU2097828714.EUR","LU1734074674.USD","LU1105468828.SGD","LU1675838814.USD","06181","LU0054450605.USD","LU0572940350.SGD","LU2097828474.EUR","BK1190","LU0211977185.USD","LU2399975544.HKD","LU0594300419.USD","LU1196710351.USD","LU1691799644.USD","LU2237443465.HKD","BK1095","LU1044876610.USD","LU0070217475.USD","SG9999013353.USD","IE00BGV7N243.SGD","LU0449515922.USD","BK1589","HK0000306685.HKD","BK1184","SGXZ90724238.SGD","IE00B3T34201.USD","LU0828237940.HKD","EVS.SI","IE00B0JY6N72.USD","LU0648948544.HKD","LU0561508036.HKD","LU0181495838.USD","LU0882747503.HKD","LU0370786039.SGD","LU0261950983.USD","LU0823397285.USD","LU2133065610.SGD","SG9999018857.SGD","GB00BDT5M118.USD","SG9999004220.SGD","LU0327786744.USD","LU1956131251.USD","09999","SG9999014674.SGD","SG9999001846.SGD","LU0228659784.USD","LU2251237306.USD","IE00B8HQ1Z84.USD","LU2476274720.SGD","LU2148510915.USD","LU0229945570.USD","LU0106959298.USD","LU0011963245.USD","LU0329678337.USD","LU1316542783.SGD","IE00B067MR52.USD","LU0890818403.SGD","LU0307460666.USD","LU1196710195.USD","LU0169518387.USD","LU0877626530.USD","BK1517","LU0509642566.USD","LU0048597586.USD","IE0004086264.USD","LU0140636845.USD","LU0197773160.USD","LU0823413660.USD","09067","LU0231483743.USD","LU0633140560.USD","07300","LU0819123356.HKD","LU0488056044.USD","LU0499858602.USD","00175","LU0326948709.USD","IE00B8L5B284.USD","03067","LU0516422952.EUR","IE00BZ08YT58.USD","LU0043850808.USD","LU2362541513.USD","LU0979878070.USD","LU2251237488.HKD","03115","SG9999014880.SGD","LU0828238088.HKD","LU0608807433.USD","SG9999015952.SGD","LU0128525689.USD","BK1594","HK0000306701.USD","BK1591","LU0132412106.USD","LU1211504680.USD","LU2008162690.USD","LU0572939691.SGD","BK1572","IE0008368411.USD","LU0359202008.SGD","LU2362540622.SGD","SG9999004303.SGD","LU2153592121.USD","LU0196878994.USD","LU0762542818.HKD","LU0791590937.USD","LU1769817179.HKD","00960","LU0878004406.USD","MCHmain","LU1051769294.HKD","SG9999018865.SGD","LU1196710864.SGD","HTCD.SI","LU2257852520.SGD","LU0345769128.USD","BK1592","LU0259732245.USD","LU0543330483.HKD","LU0048388663.USD","IE00BQXX3D17.EUR","LU1917777945.USD","LU0873338254.USD","LU0143863198.USD","LU0472753341.HKD","LU1769817096.USD","01024","LU1048588211.SGD","SG9999014914.USD","LU0235996351.USD","LNVGY","LU2265009873.SGD","LGFRY","LU0823038988.USD","IE00BQXX3C00.GBP","SG9999004311.SGD","LU1282648689.USD","SGXZ31699556.SGD","BK1544","00992","07226","LU0589944569.HKD","01952","LU0594300179.USD","01299","LU0261950470.USD","LU0828237510.HKD","LU2348773727.SGD","LU2247934214.USD","LU0149721374.USD","LU0700851271.USD","LU0164865239.USD","LU1323998911.USD","LU1725190679.HKD","LU0823426480.USD","LU0588546209.SGD","LU0310800965.SGD","LU2449936058.SGD","LU0456842615.SGD","BK1161","LU0672654166.SGD","00005","BK1227","LU0348788117.USD","LU1712237335.SGD","LU0577902298.EUR","LU0499858438.USD","LU0164872284.USD","LU0784639295.USD","LU1366334651.USD","LU1226288097.SGD","LU2242644610.SGD","LU0269904917.USD","SGXZ51526630.SGD","LU1282649141.HKD","HSI","IE00B5MMRT66.SGD","LU2778985437.USD","LU2051468812.USD","LU0348783233.USD","LU1951186391.HKD","LU2498475776.HKD","LU0821914370.USD","BK1240","LU0531971595.HKD","LU1808992512.USD","BK1521","HK0000352291.HKD","BK1615","LU0737861699.HKD","LU0251144936.SGD","LU0315179316.USD","LU1813983027.USD","LU0054237671.USD","LU0456846285.SGD","LU1993786604.SGD","00700","IE00B031HW06.USD","LU2097828557.USD","IE0003851619.USD","LU0163747925.USD","LU1623119135.USD","LU0289960550.SGD","LU0608807946.USD","LU0128522157.USD","02833","BK1191","LU0266013472.USD","03692","LU0865486749.SGD","HSTECH","IE00B031HY20.USD","LU2293587155.HKD","LU0456827905.SGD","LU0049853897.USD","LU0516422440.USD","BK1608","LU2462611646.USD","LU0096374516.USD","LU0633140727.USD","LU0823040885.USD","LU0972618739.USD","SG9999002463.SGD","SG9999000459.SGD","LU0831093199.SGD","LU0516423091.SGD","LU0985320562.USD","IE00BYQQ9H92.USD","BK1586","LU0607220059.USD","LU0431992006.USD","LU0593848301.USD","SG9999001069.SGD","LU1481012133.USD","LU2023251221.USD","LU2360107325.USD","BK1231","LU1718418525.SGD","LU0057025933.USD","LU1770036033.HKD","SGXZ81514606.USD","LU0315178854.USD","LU1983260115.SGD","GELYY","LU0158827781.USD","LU0588545730.USD","LU1130305938.SGD","LU1810669033.SGD","LU1251922891.USD","LU1400636574.HKD","LU0061477393.USD","LU0359201885.HKD","LU0634319403.HKD","LU0683595622.HKD","LU1504937902.USD","LU0072913022.USD","SG9999014021.USD","IE00BZ08YS42.EUR","LU0516423174.USD","HK0000288784.HKD","LU1224709979.USD","81299","LU0051755006.USD","LU0049112450.USD","LU0289961442.SGD","LU0611395673.USD","LU1235295612.USD","BK1516","BK1526","BK1555","LU0918141887.USD","LU1202635105.USD","LU2237443382.USD","LU0359201612.USD","BK1531","SG9999014013.SGD","LU1044875133.USD","SG9999015945.SGD","AAGIY","03417","LU0501845795.SGD","LU0084288322.USD","LU1119993845.HKD","LU0823413587.USD","LU2125910849.SGD","02837","IE00B3M56506.USD","LU1328615791.USD","LU2237443978.SGD","83115","LU0052756011.USD","LU0143863784.USD","LU1794554557.SGD","LU0128522744.USD","HK0000320264.USD","LU2045819591.USD","LU0188438112.USD","LU0557290698.USD","BK1193","LU0605514214.HKD","LU1868837722.USD","LU1785774172.SGD","LU0862451837.USD","LU0228367735.SGD","82800","80992","LU2023250504.SGD","BK1119","LU3063872942.SGD","SGXZ23171101.USD","LU0072462343.USD","BK1539","LU0417516738.SGD","LU0708995153.HKD","LU1224444064.USD","LU0052750758.USD","HK0001040143.USD","LU0577902611.USD","LU1733274390.USD","LU0396098781.USD","LU0417516902.SGD","BK1588","IE0034224299.USD","LU0254981946.USD","LU1282649810.SGD","SG9999006597.SGD","09088","LU0786609619.USD","LU0127658192.USD","SG9999006514.SGD","IE0032431581.USD","LU0640798160.USD","BK1574","IE00BZ08YR35.GBP","BK1576","LU0577902454.USD","LU1282651048.USD","LU1064131003.USD","LU0762540952.USD","BK1601","LU0630378692.HKD","LU0164880469.USD","LU0106259558.USD","LU1670756490.USD","LU2271345857.HKD","LU1008478684.HKD","LU0449509016.USD","LU1883866441.USD","LU2476274308.USD","LU1720050803.USD","LU0588545904.SGD","LU0819121731.USD","LU0287142896.SGD","BK1502","LU2237443549.SGD","LU0175139822.USD","BK1575","IE00BQXX3F31.USD","LU0348723411.USD","LU0642271901.SGD","LU0264606111.USD","LU0320764599.SGD","LU0348814723.USD","LU1719994722.HKD","LU0577902371.SGD","LU1733274473.HKD","LU0293314216.USD","LU2226246903.HKD","LU2294711473.HKD","LU1226287529.USD","LU1515016050.SGD","IE0009570106.USD","LU0955669360.SGD","03088","LU0158827948.USD","LU0511384066.AUD","SG9999000418.SGD","LU1439103000.SGD","HK0000320223.HKD","02800","LU0210527791.USD","LU0329678170.USD","LU0516422366.SGD","LU1226288170.HKD","LU1861219969.SGD","IE0008369823.USD","LU1807302812.USD","LU1328277881.USD","LU0541501648.USD","IE00B0169N27.USD","LU0328353924.USD","LU1868837565.USD","HK0001040168.HKD","LU1655091459.SGD","LU1282649067.USD","03143","HK0000151867.HKD","SG9999001226.SGD","LU0886674414.USD","SG9999001051.SGD","SG9999014906.USD","KSTmain","603993","LU0192582467.USD","LU1048484197.HKD","LU1880383440.USD","LU2177674079.SGD","LU0348766576.USD","LU2362541273.HKD","LU0831103253.SGD","LU1439102457.SGD","SG9999014039.USD","LU0197773673.USD","LU0469268626.HKD","LU1046422090.SGD","LU1868838027.USD","LU0577902538.SGD","LU0080751232.USD","LU2237443622.USD","IE00B0169L03.USD","LU0463099449.HKD","LU1048596156.SGD","LU0531970944.HKD","HSHD.SI","LU0205439572.USD","BK1618","LU0067412154.USD","LU1831875114.USD","LU0326950275.SGD","LU0898667661.SGD","LU0244354667.USD","03037","LU0455707207.USD","IE0003795394.USD","LU0417516571.SGD","SG9999015978.USD","LU2097828631.EUR","LU1282651121.HKD","SG9999002562.SGD","BK1610","LU1044874839.SGD","LU0971096721.USD","LU1568876335.HKD","LU0955648018.USD","LU0572944931.SGD","SG9999000327.SGD","LU0165289439.USD","LU0588545490.SGD","LU0029875118.USD","LU0823041008.USD","LU1568876251.USD","LU0738912210.USD","LU0320764755.SGD","LU1629966141.USD","80175","LU0348805143.USD","81024","BK1104","LU0048575426.USD","LU2089284900.SGD","LU0651947912.USD","LU0289739343.SGD","LU0348735423.USD","LU1226288253.USD","BK1141","LU2087589342.USD","LU1821325948.USD","03423","LU2028103732.USD","HSBA.UK","SG9999002828.SGD","LU0441854154.USD","LU0106252389.USD","HK0000914686.HKD","HK0000352382.USD","IE00BKZH1Z71.USD","LU0214875030.USD","LU2125910500.SGD","LU0797268264.HKD","HSBC","LU0210526637.USD","IE00B031J352.USD","LU0345769631.USD","SG9999001689.USD","IE00B543WZ88.USD","LU0117844026.USD","LU0955623706.USD","LU2929501877.USD","LU1861214812.USD","SG9999001903.USD","LU0117841782.USD","LU0878005551.USD","SG9999017495.SGD","LU0029874905.USD","03033","LU0107464264.USD","IE00B97KM107.HKD","LU0762541174.USD","LU0039217434.USD","LU2317271919.USD","LU0261947096.USD","BK1609","IE0008368742.USD","LU1400636657.SGD","SG9999001093.SGD","IE0031814852.USD","09115","LU0862451753.SGD","LU2111349929.HKD","BK1583","LU0203347892.USD","LU0414403682.SGD","LU0173614495.USD","LU0047713382.USD","LU0823397103.USD","LU0708995583.HKD","LU1102505929.USD","LU1688375341.USD","LU0384037296.USD","IE0032834883.USD","LU1267930227.SGD","LU0203345920.USD","LU0345775950.USD","LU2153591404.USD","07200","IE00B5TLWC47.USD","LU0856984785.SGD","LU1770034418.SGD","SG9999015986.USD","BK1590","513600","IE00B29SXG58.USD","LU0650527681.SGD","LU0791591158.USD","LU0314109678.HKD","LU2237443895.HKD","LU1974910355.USD","LU0540923850.HKD","LU2039709279.SGD","LU0871576103.HKD","LU0345776255.USD","LU0823426308.USD","LU1642822792.SGD","LU1804176565.USD","LU0541502299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641146295","title":"新华健康丨翰森制药双靶点GLP-1减重药奥莱泊肽NDA获受理 将面临激烈市场竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2641146295","media":"经济参考网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641146295?lang=zh_cn&edition=full","pubTime":"2026-06-05 22:30","pubTimestamp":1780669858,"startTime":"0","endTime":"0","summary":"翰森制药（03692.HK）发布公告称，6月3日，公司创新药奥莱泊肽注射液上市许可申请（NDA）获国家药监局（NMPA）受理，适用于肥胖或超重成人的长期体重管理。此举标志着翰森制药补齐代谢领域核心拼图，正式进入全球最热门的代谢疾病赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053762285376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","03692","BK4144","BK4590","BK1583","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641939531","title":"《21健讯Daily》|翰森制药减重新药申报上市；艾德生物复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641939531","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641939531?lang=zh_cn&edition=full","pubTime":"2026-06-05 08:02","pubTimestamp":1780617724,"startTime":"0","endTime":"0","summary":"政策动向世卫组织总干事呼吁建立长期医疗防御机制应对埃博拉疫情6月3日，世界卫生组织总干事谭德塞在当天的新闻发布会上强调，控制埃博拉疫情只是时间问题，但真正的成功应在于预防未来的疫情。谭德塞表示，世卫组织在全力应对当前疫情的同时，将致力于协助当地政府建设和完善长期的医疗与人道主义服务体系，打破“头痛医头”的循环。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606053760994263.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053760994263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1583","03692","IPOS","LU2460026573.USD","BK0042","BK0239","IE0005HP3H50.USD","300685","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124914141","title":"翰森制药拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1124914141","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124914141?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:08","pubTimestamp":1780571289,"startTime":"0","endTime":"0","summary":"翰森制药公告称，将于2026年6月26日在香港召开股东周年大会，审议并表决是否批准公司进行股份购回授权。该授权规模最高可达公司于股东周年大会当日已发行股份总量的10%，约合6.06亿股。董事会认为，此举有助于提升每股盈利、维护投资者权益，并符合公司及股东的整体最佳利益；实际购回安排会根据市场环境与资本状况进行。董事会将于大会上向股东进一步说明本次购回计划的细节。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰森制药拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2640135180","title":"国产双靶点GLP-1迎新进展，翰森制药减重新药申报获受理｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2640135180","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640135180?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:57","pubTimestamp":1780538268,"startTime":"0","endTime":"0","summary":"截至6月3日收盘，市场冲高回落，沪深两市成交额3.13万亿元。医药ETF（512120）下跌1.46%，港股通生物科技ETF（159102）下跌3.11%。相关个股方面，金斯瑞生物科技上涨10.54%、信达生物下跌2.54%、百济神州下跌2.13%、药明生物下跌7.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606043760000889.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606043760000889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","BK1583","BK1161","GLP","09939","159938","BK1574","BK1589","03692","BK1191","BK1515","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640180529","title":"翰森制药(03692)：奥莱泊肽注射液上市许可申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640180529","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640180529?lang=zh_cn&edition=full","pubTime":"2026-06-04 07:39","pubTimestamp":1780529964,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，于2026年6月3日，集团创新药奥莱泊肽注射液上市许可申请(NDA)获中国国家药品监督管理局(NMPA)受理，适用于肥胖或超重成人的长期体重管理。奥莱泊肽是一款集团自主研发的每周一次给药胰高血糖素样肽-1(GLP-1)╱葡萄糖依赖性促胰岛素多肽(GIP)双受体激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","IPOS","BK1191","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100775475","title":"翰森制药：奥拉托肽注射液新药上市申请获中国国家药监局受理 用于慢性体重管理","url":"https://stock-news.laohu8.com/highlight/detail?id=1100775475","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100775475?lang=zh_cn&edition=full","pubTime":"2026-06-04 07:31","pubTimestamp":1780529475,"startTime":"0","endTime":"0","summary":"翰森制药宣布，其用于慢性体重管理的创新药奥拉托肽注射液的新药上市申请，已获得中国国家药品监督管理局的受理。\n此次受理标志着该药物在中国商业化进程中的关键一步。若最终获批，奥拉托肽注射液将为国内慢性体重管理领域提供新的治疗选择。\n公司表示将继续与监管机构保持密切沟通，积极推进后续审评工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109494137","title":"翰森制药5月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109494137","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109494137?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:49","pubTimestamp":1780390184,"startTime":"0","endTime":"0","summary":"翰森制药于2026年6月2日披露2026年5月股份变动月报表，显示公司截至2026年5月31日的注册股本与已发行股本均保持不变。根据公告，翰森制药目前的法定/注册股本数量为20,000,000,000股，面值为每股港币0.00001，总额约为20万元。本次月报表由联席公司秘书钟胜利女士签署，公司声明其已遵守香港联交所《上市规则》及相关法律法规的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638166837","title":"港股异动 | 创新药概念股集体走低 加息预期压制行业估值及投融资环境 市场关注ASCO会议进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2638166837","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638166837?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:09","pubTimestamp":1779952150,"startTime":"0","endTime":"0","summary":"创新药、CXO 等成长赛道对流动性较为敏感，若美联储降息周期延后，或国内降准降息落地不及预期，市场流动性收紧将直接压制成长赛道估值。值得注意的是，2026年美国临床肿瘤学会年会将于5月29日至6月2日在美国芝加哥举行。本届ASCO共63项研究入选LBA，其中12家企业的13项研究来自中国，创历史新高；同时，94项中国研究入选口头汇报，数量近三年快速增长。上海证券指出，中国药企在国际平台彰显实力，中国创新药全球话语权逐年提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IE00BZ08YR35.GBP","06978","LU2097828805.USD","LU2097828474.EUR","BK1587","BK1574","BK1589","LU2488822045.USD","LU0455707207.USD","LU2328871848.SGD","IE00BZ08YS42.EUR","BK1588","VXUS","HK0000165453.HKD","159992","LU2097828557.USD","LU1969619763.USD","LU2097828631.EUR","03692","BK1191","BK1161","LU0502904849.HKD","BK1521","BK1583","LU2242644610.SGD","01177","00013","01801","BK1515","BK4588","LU2097828714.EUR","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160060542","title":"异动解读｜翰森制药盘中下跌6.04%，报31.76港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160060542","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160060542?lang=zh_cn&edition=full","pubTime":"2026-05-28 13:41","pubTimestamp":1779946909,"startTime":"0","endTime":"0","summary":"5月28日，翰森制药盘中下跌6.04%，报31.76港元/股，成交额1.71亿港元。翰森制药所在的制药行业中，板块整体承压，个股中，石药集团跌1.56%，中国生物制药跌3.4%，恒瑞医药跌2.24%，康哲药业跌4.15%，和黄医药跌4.71%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585985","title":"中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638585985?lang=zh_cn&edition=full","pubTime":"2026-05-25 13:59","pubTimestamp":1779688785,"startTime":"0","endTime":"0","summary":"参照恒指公司的行业分类，此次恒指调整后，对于医疗保健业的覆盖度从38.8%提升至44.3%，对于工业的覆盖度从54.3%提升至56.0%。该行根据此次恒生综合指数调整情况、结合港股通纳入的额外要求，预计6只或符合港股通纳入范围。此次进入恒生综合指数的Minimax-W由于其同股不同权性质，需额外满足上市满6个月及20个交易日的条件，因此不会在本次6月调整中进入港股通，预计于8月纳入港股通。若后续满足市值与成交额要求，有望于8月纳入港股通。","market":"sh","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7ab48a17674d5845193952fa54058c28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445467.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07200","HSI","07300","03032","LU0348766576.USD","601600","HSCI","688235","LU0307460666.USD","BK1568","LU2476274308.USD","LU0348827113.USD","BK1191","LU1251922891.USD","LU1808992512.USD","HSTECH","07500","09926","09088","06160","BK1583","BK1513","IE00BPRC5H50.USD","LU2778985437.USD","09115","BK1574","HHImain","LU0348783233.USD","BK1117","LU0540923850.HKD","03037","LU0588546209.SGD","LU0348825331.USD","BK1592","BK1588","03088","07588","LU0561508036.HKD","03417","LU2328871848.SGD","ONC","LU0417516571.SGD","03423","03115","02837","00100","HSCEI","BK1589","02833","BK1500","07552","82800","MCHmain","09067","LU0634319403.HKD","LU1961090484.USD","01519","LU1303224171.USD","LU0417516738.SGD","LU0417516902.SGD","02828","LU2476274720.SGD","BK1175","03033","82828","BK1151","LU0348735423.USD","LU0348784397.USD","BK1161","LU0348767384.USD","LU1770034418.SGD","03419","07226","IE00B5MMRT66.SGD","02600","03416","LU1794554557.SGD","83115","LU2399975544.HKD","02800","LU1719994722.HKD","IE00B543WZ88.USD","03067","07288","LU1969619763.USD","02513","HK0000286598.CNH","LU1720050803.USD","03692","LU2488822045.USD","513600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637984387","title":"翰森制药(03692)：第四代EGFR-TKI HS-10504片用于非小细胞肺癌纳入突破性治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2637984387","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637984387?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:42","pubTimestamp":1779360179,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，于2026年5月21日，本集团自研第四代表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)HS-10504片获中国国家药品监督管理局(NMPA)批准纳入突破性治疗药物，拟定适应症为用于经EGFR-TKI治疗失败后伴EGFR C797S突变的局部晚期或转移性非小细胞肺癌(NSCLC)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰森制药(03692)：第四代EGFR-TKI HS-10504片用于非小细胞肺癌纳入突破性治疗药物","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1589","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087677","title":"翰森制药(03692)：曾昭获委任为联席公司秘书、授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087677","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635087677?lang=zh_cn&edition=full","pubTime":"2026-05-15 21:03","pubTimestamp":1778850184,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，李亮贤先生由于个人工作安排已辞任公司联席公司秘书一职，并不再担任香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表，以及上市规则第19.05(2)条及公司条例(香港法例第622章)第16部项下所规定代表公司于香港接收法律程序文件及通知的公司授权代表(法律程序文件代理人)，自2026年5月15日起生效。曾昭女士已获委任为联席公司秘书、授权代表及法律程序文件代理人，自2026年5月15日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","BK1191","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635114782","title":"翰森制药(03692)：HS-10541片获国家药监局签发的药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2635114782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635114782?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:34","pubTimestamp":1778675685,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，集团自主研发的1类新药HS-10541片获中国国家药品监督管理局(NMPA)签发的药物临床试验批准通知书，拟开展“用于KRAS G12C突变晚期实体瘤的治疗”的临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","BK1589","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01024","03700","02158","01951","03692","00762","02013","81024","01905","00772","02197","06186","02618","03888","06660","09992","02256","06963","01357","00909","02192","09699","01952","00136","02276","02252","02306","06160","02126","06969","02171","06049","06996","09626","01783","01060","01440","00719","00013","02285","06060","02096","02172","00169","01548","06609","09688","09858","09888","01833"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.1222},{"period":"3month","weight":-0.0591},{"period":"6month","weight":-0.209},{"period":"1year","weight":0.0465},{"period":"ytd","weight":-0.1796}],"compareEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":-0.0886},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0962},{"period":"1year","weight":-0.0149},{"period":"ytd","weight":-0.0895}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统（CNS）疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.01282},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023369},{"month":4,"riseRate":0.571429,"avgChangeRate":0.03396},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.00521},{"month":6,"riseRate":0.571429,"avgChangeRate":0.039315},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}